Differential requirement for interferon-γ to restrict the growth of or eliminate some recently identified species of nontuberculous mycobacteria in vivo

Clinical and Experimental Immunology

Volumn 124, Issue 2, 2001, Pages 229-238

  Ehlers, S ^a   Richter, E ^a  

^a RESEARCH CENTER BORSTEL   (Germany)

Author keywords

Animal model; Granuloma; IFN ; Immunodeficiency; Mycobacterium; Nontuberculous

Indexed keywords

GAMMA INTERFERON;

ANIMAL MODEL; ARTICLE; BACTERIAL COUNT; BACTERIAL GROWTH; BACTERIAL VIRULENCE; BACTERIUM IDENTIFICATION; CONTROLLED STUDY; GROWTH INHIBITION; IMMUNOHISTOLOGY; LIVER GRANULOMA; LYMPHADENOPATHY; MOUSE; MYCOBACTERIUM; MYCOBACTERIUM BOHEMICUM; MYCOBACTERIUM BRANDERI; MYCOBACTERIUM CELATUM; MYCOBACTERIUM CONFLUENTIS; MYCOBACTERIUM CONSPICUUM; MYCOBACTERIUM HEIDELBERGENSE; MYCOBACTERIUM INTERJECTUM; MYCOBACTERIUM INTERMEDIUM; MYCOBACTERIUM LENTIFLAVUM; MYCOBACTERIUM MALMOENSE; MYCOBACTERIUM XENOPEI; NONHUMAN; PRIORITY JOURNAL; SPECIES DIFFERENCE; SPLENOMEGALY;

ANIMALS; IMMUNOCOMPETENCE; INTERFERON TYPE II; LYMPHATIC DISEASES; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; MYCOBACTERIUM; MYCOBACTERIUM INFECTIONS; NECK; OPPORTUNISTIC INFECTIONS; SPECIES SPECIFICITY; SPLENOMEGALY;

EID: 0034955122     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2001.01509.x     Document Type: Article

References (59)

1. Epidemiology of infection by nontuberculous mycobacteria
2. Isolation of environmental mycobacteria from clinical specimens in south-east England: 1973-93
3. Clinical and radiographic manifestations of uncommon pulmonary nontuberculous mycobacterial disease in AIDS patients
4. Mycobacterial diseases other than tubemulosis
5. Mycobacteria other than Mycobacterium tuberculosis: Review of microbiologic and clinical aspects
6. Mycobacterium avium and the normal host. The other side of the coin
7. The Mycobacterium avium complex
8. Pulmonary infection due to Mycobacterium xenopi
9. Mycobacterium malmoense infections in immunocompetent patients
10. Towards a phylogeny and definition of species at the molecular level within the genus Mycobacterium
11. A new agent of mycobacterial lymphadenitis in children: Mycobacterium heidelbergense sp. nov.
12. Isolation and characterization of a unique group of slowly growing mycobacteria: Description of Mycobacterium lentiflavum sp. nov.
13. Mycobacterium lentiflavum: An etiologic agent of cervical lymphadenitis
14. Mycobacterium interjectum, a new species isolated from a patient with chronic lymphadenitis
15. Phenotypic and molecular characterization of three clinical isolates of Mycobacterium interjectum
16. Chronic destructive lung disease associated with a novel mycobacterium
17. Mycobacterium intermedium sp
18. Mycobacterium bohemicum sp. nov., a new slow-growing scotochromogenic mycobacterium
19. Mycobacterium branderi sp. nov., a new potential human pathogen
20. Mycobacterium confluentis sp
21. Isolation of Mycobacterium celatum from patients infected with human immunodeficiency virus
22. Cervical lymphadenitis caused by Mycobacterium celatum
23. Disseminated infection due to Mycobacterium celatum in patients with AIDS
24. Mycobacterium conspicuum sp.nov., a new species isolated from patients with disseminated infections
25. Mouse model of tuberculosis
26. Different types of pulmonary granuloma necrosis in immunocompetent vs. TNFRp55-gene-deficient mice aerogenically infected with highly virulent Mycobacterium avium
27. Immune responses to tuberculosis
28. Mechanisms of granuloma formation in murine Mycobacterium avium infection: The contribution of CD4+ T cells
29. Role of gamma interferon and tumor necrosis factor alpha during T-cell-independent and -dependent phases of Mycobacterium avium infection
30. T cell independent mechanisms of granuloma formation in M. avium infection: Role of TNFα and IFNγ
31. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection
32. Disseminated tuberculosis in interferon gamma gene-disrnpted mice
33. Resistance of virulent Mycobacterium avium to gamma interferon-mediated antimicrobial activity suggests additional signals for induction of mycobacteriostasis
34. A mutation in the interferon-γ-receptor gene and susceptibility to mycobacterial infection
35. Defective monocyte costimulation for IFN-gamma production in familial disseminated Mycobacterium avium complex infection: Abnormal IL-12 regulation
36. A human IFNGR1 small deletion hotspot associated with dominant susceptibility to mycobacterial infection
37. Natural resistance to infection with intracellular parasites: Molecular genetics identifies Nrampl as the Bcg/Ity/Lsh locus
38. The role of macrophage activation and of Bcg-encoded macrophage function(s) in the control of Mycobacterium avium infection in mice
39. Isolation and direct complete nucleotide determination of entire genes: Characterization of a gene coding for 16S ribosomal RIGA
40. Assessment of mycobacterial DNA in cells and tissues of mycobacterial and sarcoid lesions
41. Detection and identification of mycobacteria by amplification of rRNA
42. Gapped BLAST PSI-BLAST. A new generation of protein database search programs
43. Bias of culture techniques for diagnosing mixed Mycobacterium genavense and Mycobacterium avium infection in AIDS
44. Pneumonia and bacteriemia due to Mycobacterium celatum masquerading as Mycobacterium xenopi in patients with AIDS: An underdiagnosed problem?
45. Extrapulmonary and disseminated infections due to Mycobacterium malmoense: Case report and review
46. Mycobacterium xenopi: Innocent bystander or emerging pathogen?
47. Mycobacteria other than tuberculosis with an emphasis on Mycobacterium xenopi in clincial specimens from AIDS patients at the University Hospital of Vienna from 1989 to 1996
48. Cervical lymphadenitis due to Mycobacterium bohemicum
49. Fatal pulmonary infection with Mycobacterium celatum in an apparently immunocompetent patient
50. Mycobacterium heidelbergense species nov. infection mimicking a lung tumor
51. Virulence ranking of some Mycobacterium tuberculosis and Mycobacterium boris strains according to their ability to multiply in the lungs, induce lung pathology, and cause mortality in mice
52. Gamma interferon is essential for clearing Mycobacterium genavense infection
53. Spectrum of disease due to rapidly growing mycobacteria
54. Nontuberculous mycobacterial infections of the skin
55. Interferon-gamma and interleukin-12 pathway defects and human disease
56. Identification of nitric oxide synthase 2 as a protective locus against tuberculosis
57. NOS2-derived nitric oxide regulates the size, quantity and quality of granuloma formation in Mycobacterium avium-infected mice without affecting bacterial loads
58. Improved clearance of Mycobacterium avium upon disruption of the inducible nitric oxide synthase gene